Daily Note 09/01/2024 – Market View: Day Ahead, Macro, Stocks, Debt Markets


  • Macro: It was a risk on session for risk assets yesterday, with Europe and the US indices all ending the day in the green, as investors repositioned themselves following the sell-off during the opening week of the year.
  • Stock: GSK has entered into an agreement to buy Asthma specialist Aiolos Bio for $1bn in upfront cash, with the possibility for the payments increasing to $1.4bn given certain regulatory milestones are achieved.
  • Debt: Core bond yields were modestly lower yesterday as traders awaited US CPI data on Thursday.